Treatment outcomes and validation of the stopping rule for response to peginterferon in chronic hepatitis B: A Thai nationwide cohort study

由 Charatcharoenwitthaya P., Sukeepaisarnjaroen W., Piratvisuth T., Thongsawat S., Sanpajit T., Chonprasertsuk S., Jeamsripong W., Sripariwuth E., Komolmit P., Patcharatrakul T., Boonsirichan R., Bunchorntavakul C., Tuntipanichteerakul S., Tanwandee T.
出版 2017

Genetic variation in the Vitamin D pathway CYP2R1 gene predicts sustained HBeAg seroconversion in chronic hepatitis B patients treated with pegylated interferon: A multicenter stud...

由 Thanapirom K., Suksawatamnuay S., Sukeepaisarnjareon W., Tanwandee T., Charatcharoenwitthaya P., Thongsawat S., Leerapun A., Piratvisuth T., Boonsirichan R., Bunchorntavakul C., Pattanasirigool C., Pornthisarn B., Tantipanichtheerakul S., Sripariwuth E., Jeamsripong W., Sanpajit T., Poovorawan Y., Komolmit P.
出版 2017

Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3

由 Pianko S., Zeuzem S., Chuang W.-L., Foster G.R., Sarin S.K., Flisiak R., Lee C.-M., Andreone P., Piratvisuth T., Shah S., Sood A., George J., Gould M., Komolmit P., Thongsawat S., Tanwandee T., Rasenack J., Li Y., Pang M., Yin Y., Feutren G., Jacobson I.M.
出版 2014

Randomized trial of albinterferon alfa-2b every 4 weeks for chronic hepatitis C virus genotype 2/3

由 Pianko S., Zeuzem S., Chuang WL., Foster GR., Sarin SK., Flisiak R., Lee CM., Andreone P., Piratvisuth T., Shah S., Sood A., George J., Gould M., Komolmit P., Thongsawat S., Tanwandee T., Rasenack J., Li Y., Pang M., Yin Y., Feutren G., Jacobson IM., for the B2202 Study Team.
出版 2014